Skip to main content
Top
Published in: Journal of Neuro-Oncology 2/2016

01-09-2016 | Letter to the Editor

Brain tumors incidences and a retrospective clinical analysis from a tertiary hospital in India

Authors: Ravindra Pramod Deshpande, Deepak Babu, Manas Panigrahi, Y. B. V. K. Chandra Sekhar, Phanithi Prakash Babu

Published in: Journal of Neuro-Oncology | Issue 2/2016

Login to get access

Excerpt

Brain tumor is a collection of abnormally grown cells in brain, contributing total 256,213 new cases reported globally in 2012. In USA, 68,470 brain tumor cases were reported in the year 2015 [1]. Overall, males are reported to be more prone to brain tumors than females with 7.7 males and 5.4 females per 100,000 persons [2]. World Health Organization (WHO) has classified brain tumors into diverse groups based on histopathological features and cellular origin [3]. Among all groups, gliomas appear to be the most common primary brain tumors [1, 3]. Despite of aggressive chemo and radio therapy, the median survival age for malignant gliomas is very low [4]. …
Literature
3.
go back to reference Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, Scheithauer BW, Kleihues P (2007) The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 114(2):97–109CrossRefPubMedPubMedCentral Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, Scheithauer BW, Kleihues P (2007) The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 114(2):97–109CrossRefPubMedPubMedCentral
4.
go back to reference Van den Bent MJ, Bromberg JE (2015) Neuro-oncology: the many challenges of treating elderly glioblastoma patients. Nat Rev Neurol 11(7):374–375CrossRefPubMed Van den Bent MJ, Bromberg JE (2015) Neuro-oncology: the many challenges of treating elderly glioblastoma patients. Nat Rev Neurol 11(7):374–375CrossRefPubMed
5.
go back to reference Davis F, McCarthy BJ, Berger MS (1999) Centralized databases available for describing primary brain tumor incidence, survival, and treatment: central brain tumor registry of the United States; surveillance, epidemiology, and end results; and National Cancer Data Base. Neuro-oncology 1(3):205–211PubMedPubMedCentral Davis F, McCarthy BJ, Berger MS (1999) Centralized databases available for describing primary brain tumor incidence, survival, and treatment: central brain tumor registry of the United States; surveillance, epidemiology, and end results; and National Cancer Data Base. Neuro-oncology 1(3):205–211PubMedPubMedCentral
7.
go back to reference Jalali R, Datta D (2008) Prospective analysis of incidence of central nervous tumors presenting in a tertiary cancer hospital from India. J Neuro-oncol 87:111–114CrossRef Jalali R, Datta D (2008) Prospective analysis of incidence of central nervous tumors presenting in a tertiary cancer hospital from India. J Neuro-oncol 87:111–114CrossRef
8.
go back to reference Babu R, Sharma R, Bagley JH, Hatef J, Friedman AH, Adamson C (2013) Vestibular schwannomas in the modern era: epidemiology, treatment trends, and disparities in management. J Neurosurg 119(1):121–130CrossRefPubMed Babu R, Sharma R, Bagley JH, Hatef J, Friedman AH, Adamson C (2013) Vestibular schwannomas in the modern era: epidemiology, treatment trends, and disparities in management. J Neurosurg 119(1):121–130CrossRefPubMed
9.
go back to reference Kivelev J, Niemelä M, Blomstedt G, Roivainen R, Lehecka M, Hernesniemi J (2011) Microsurgical treatment of temporal lobe cavernomas. Acta Neurochir (Wien) 153(2):261–270CrossRef Kivelev J, Niemelä M, Blomstedt G, Roivainen R, Lehecka M, Hernesniemi J (2011) Microsurgical treatment of temporal lobe cavernomas. Acta Neurochir (Wien) 153(2):261–270CrossRef
10.
go back to reference Chang SM, Parney IF, Huang W, Anderson FA Jr, Asher AL, Bernstein M, Lillehei KO, Brem H, Berger MS, Laws ER (2005) Patterns of care for adults with newly diagnosed malignant glioma. JAMA 293(5):557–564CrossRefPubMed Chang SM, Parney IF, Huang W, Anderson FA Jr, Asher AL, Bernstein M, Lillehei KO, Brem H, Berger MS, Laws ER (2005) Patterns of care for adults with newly diagnosed malignant glioma. JAMA 293(5):557–564CrossRefPubMed
11.
go back to reference Perry A, Stafford SL, Scheithauer BW, Suman VJ, Lohse CM (1997) Meningioma grading: an analysis of histologic parameters. Am J Surg Path 21:1455–1465CrossRefPubMed Perry A, Stafford SL, Scheithauer BW, Suman VJ, Lohse CM (1997) Meningioma grading: an analysis of histologic parameters. Am J Surg Path 21:1455–1465CrossRefPubMed
12.
go back to reference Fisher JL, Schwartzbaum JA, Wrensch M, Wiemels JL (2007) Epidemiology of brain tumors. Neurol Clin 25(4):867–890 (vii)CrossRefPubMed Fisher JL, Schwartzbaum JA, Wrensch M, Wiemels JL (2007) Epidemiology of brain tumors. Neurol Clin 25(4):867–890 (vii)CrossRefPubMed
13.
go back to reference Cobbs CS, Harkins L, Samanta M, Gillespie GY, Bharara S, King PH, Nabors LB, Cobbs CG, Britt WJ (2002) Human cytomegalovirus infection and expression in human malignant glioma. Cancer Res 62(12):3347–3350PubMed Cobbs CS, Harkins L, Samanta M, Gillespie GY, Bharara S, King PH, Nabors LB, Cobbs CG, Britt WJ (2002) Human cytomegalovirus infection and expression in human malignant glioma. Cancer Res 62(12):3347–3350PubMed
14.
go back to reference Mitchell DA, Xie W, Schmittling R, Learn C, Friedman A, McLendon RE, Sampson JH (2008) Sensitive detection of human cytomegalovirus in tumors and peripheral blood of patients diagnosed with glioblastoma. Neuro-oncology 10(1):10–18CrossRefPubMedPubMedCentral Mitchell DA, Xie W, Schmittling R, Learn C, Friedman A, McLendon RE, Sampson JH (2008) Sensitive detection of human cytomegalovirus in tumors and peripheral blood of patients diagnosed with glioblastoma. Neuro-oncology 10(1):10–18CrossRefPubMedPubMedCentral
15.
go back to reference Lehrer S, Labombardi V, Green S, Pessin-Minsley MS, Germano IM, Rosenzweig KE (2011) No circulating cytomegalovirus in five patients with glioblastoma multiforme. Anticancer Res 31(3):959–960PubMed Lehrer S, Labombardi V, Green S, Pessin-Minsley MS, Germano IM, Rosenzweig KE (2011) No circulating cytomegalovirus in five patients with glioblastoma multiforme. Anticancer Res 31(3):959–960PubMed
16.
17.
go back to reference Lehrer S, Green S, Ramanathan L, Rosenzweig K, Labombardi V (2012) No consistent relationship of glioblastoma incidence and cytomegalovirus seropositivity in whites, blacks, and Hispanics. Anticancer Res 32(3):1113–1115PubMed Lehrer S, Green S, Ramanathan L, Rosenzweig K, Labombardi V (2012) No consistent relationship of glioblastoma incidence and cytomegalovirus seropositivity in whites, blacks, and Hispanics. Anticancer Res 32(3):1113–1115PubMed
18.
go back to reference Lehrer S (2012) Cytomegalovirus infection in early childhood may be protective against glioblastoma multiforme, while later infection is a risk factor. Med Hypotheses 78(5):657–658CrossRefPubMed Lehrer S (2012) Cytomegalovirus infection in early childhood may be protective against glioblastoma multiforme, while later infection is a risk factor. Med Hypotheses 78(5):657–658CrossRefPubMed
Metadata
Title
Brain tumors incidences and a retrospective clinical analysis from a tertiary hospital in India
Authors
Ravindra Pramod Deshpande
Deepak Babu
Manas Panigrahi
Y. B. V. K. Chandra Sekhar
Phanithi Prakash Babu
Publication date
01-09-2016
Publisher
Springer US
Published in
Journal of Neuro-Oncology / Issue 2/2016
Print ISSN: 0167-594X
Electronic ISSN: 1573-7373
DOI
https://doi.org/10.1007/s11060-016-2183-0

Other articles of this Issue 2/2016

Journal of Neuro-Oncology 2/2016 Go to the issue